Chicago Trust CO Na Abbott Laboratories Transaction History

Chicago Trust CO Na

  • $411 Million
  • Q2 2024

A detailed history of Chicago Trust CO Na transactions in Abbott Laboratories stock. As of the latest transaction made, Chicago Trust CO Na holds 102,250 shares of ABT stock, worth $11.6 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares
102,250
Previous 106,310 3.82%
Holding current value
$11.6 Million
Previous $12.1 Million 12.07%
% of portfolio
2.58%
Previous 3.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024
SELL
$100.73 - $112.44 $408,963 - $456,506
-4,060 Reduced 3.82%
102,250 $10.6 Million
Q1 2024

Apr 12, 2024
SELL
$109.52 - $120.96 $248,610 - $274,579
-2,270 Reduced 2.09%
106,310 $12.1 Million
Q4 2023

Jan 16, 2024
SELL
$90.19 - $110.4 $560,260 - $685,804
-6,212 Reduced 5.41%
108,580 $12 Million
Q3 2023

Oct 27, 2023
SELL
$95.53 - $114.62 $376,770 - $452,061
-3,944 Reduced 3.32%
114,792 $11.1 Million
Q2 2023

Jul 19, 2023
SELL
$100.78 - $112.29 $93,221 - $103,868
-925 Reduced 0.77%
118,736 $12.9 Million
Q1 2023

Apr 11, 2023
BUY
$96.86 - $114.01 $1.3 Million - $1.54 Million
13,465 Added 12.68%
119,661 $12.1 Million
Q4 2022

Jan 12, 2023
SELL
$95.06 - $111.52 $430,051 - $504,516
-4,524 Reduced 4.09%
106,196 $11.7 Million
Q3 2022

Oct 13, 2022
BUY
$96.76 - $112.03 $71,312 - $82,566
737 Added 0.67%
110,720 $10.7 Million
Q2 2022

Aug 03, 2022
BUY
$102.07 - $123.37 $254,256 - $307,314
2,491 Added 2.32%
109,983 $12 Million
Q1 2022

Apr 12, 2022
SELL
$114.02 - $139.04 $373,187 - $455,077
-3,273 Reduced 2.95%
107,492 $12.7 Million
Q4 2021

Jan 18, 2022
BUY
$115.53 - $141.46 $128,122 - $156,879
1,109 Added 1.01%
110,765 $15.6 Million
Q3 2021

Oct 13, 2021
BUY
$116.66 - $129.06 $390,694 - $432,221
3,349 Added 3.15%
109,656 $13 Million
Q2 2021

Jul 21, 2021
BUY
$105.79 - $124.53 $7.46 Million - $8.78 Million
70,534 Added 197.17%
106,307 $12.3 Million
Q1 2021

Apr 12, 2021
BUY
$108.84 - $128.23 $16,108 - $18,978
148 Added 0.42%
35,773 $4.29 Million
Q4 2020

Jan 28, 2021
SELL
$105.0 - $114.42 $112,560 - $122,658
-1,072 Reduced 2.92%
35,625 $3.9 Million
Q3 2020

Oct 08, 2020
SELL
$91.64 - $111.29 $497,330 - $603,970
-5,427 Reduced 12.88%
36,697 $3.99 Million
Q2 2020

Jul 13, 2020
BUY
$76.57 - $98.0 $459 - $588
6 Added 0.01%
42,124 $3.85 Million
Q1 2020

Apr 07, 2020
SELL
$62.82 - $91.86 $102,899 - $150,466
-1,638 Reduced 3.74%
42,118 $3.32 Million
Q4 2019

Jan 13, 2020
SELL
$78.51 - $87.4 $1,099 - $1,223
-14 Reduced 0.03%
43,756 $3.8 Million
Q3 2019

Oct 09, 2019
BUY
$81.84 - $88.74 $88,796 - $96,282
1,085 Added 2.54%
43,770 $3.66 Million
Q2 2019

Jul 23, 2019
SELL
$72.88 - $85.0 $865,668 - $1.01 Million
-11,878 Reduced 21.77%
42,685 $3.59 Million
Q1 2019

Apr 10, 2019
SELL
$66.22 - $80.06 $2.28 Million - $2.76 Million
-34,478 Reduced 38.72%
54,563 $4.36 Million
Q4 2018

Jan 09, 2019
SELL
$65.56 - $74.27 $118,204 - $133,908
-1,803 Reduced 1.98%
89,041 $6.44 Million
Q3 2018

Oct 10, 2018
SELL
$60.81 - $73.36 $1.54 Million - $1.86 Million
-25,364 Reduced 21.83%
90,844 $6.66 Million
Q2 2018

Jul 12, 2018
BUY
$57.57 - $63.54 $348,413 - $384,544
6,052 Added 5.49%
116,208 $7.09 Million
Q1 2018

May 11, 2018
SELL
$56.27 - $63.62 $106,687 - $120,623
-1,896 Reduced 1.69%
110,156 $6.6 Million
Q4 2017

Jan 17, 2018
BUY
$53.68 - $57.47 $186,162 - $199,305
3,468 Added 3.19%
112,052 $6.39 Million
Q3 2017

Oct 16, 2017
BUY
$48.06 - $53.64 $5.22 Million - $5.82 Million
108,584
108,584 $5.79 Million

Others Institutions Holding ABT

# of Institutions
3,131
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Chicago Trust CO Na Portfolio

Follow Chicago Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Trust CO Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email